Identification of phenocopies improves prediction of targeted therapy response over DNA mutations alone
Abstract DNA mutations in specific genes can confer preferential benefit from drugs targeting those genes. However, other molecular perturbations can “phenocopy” pathogenic mutations, but would not be identified using standard clinical sequencing, leading to missed opportunities for other patients t...
| Published in: | npj Genomic Medicine |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2022-10-01
|
| Online Access: | https://doi.org/10.1038/s41525-022-00328-7 |
